-+ 0.00%
-+ 0.00%
-+ 0.00%

TELA Bio shareholders approve 3.5 million-share increase to equity incentive plan

PUBT·06/11/2026 20:07:07
Listen to the news
TELA Bio shareholders approve 3.5 million-share increase to equity incentive plan
  • TELA Bio held its annual shareholder meeting on June 9, 2026.
  • Shareholders endorsed an amendment to the Amended and Restated 2019 Equity Incentive Plan, adding 3,500,000 authorized shares.
  • The plan amendment became effective immediately upon shareholder approval.
  • Shareholders ratified KPMG as independent registered public accounting firm for fiscal 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. TELA Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-072931), on June 11, 2026, and is solely responsible for the information contained therein.